HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Abnormalities, Multiple D000015 13 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Bacterial Infections D001424 21 associated lipids
Blister D001768 16 associated lipids
Body Weight D001835 333 associated lipids
Bone Diseases D001847 4 associated lipids
Brain Diseases D001927 27 associated lipids
Brain Neoplasms D001932 15 associated lipids
Breast Neoplasms D001943 24 associated lipids
Calcinosis D002114 5 associated lipids
Candidiasis D002177 3 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Carcinosarcoma D002296 7 associated lipids
Cerebellar Neoplasms D002528 9 associated lipids
Intracranial Embolism and Thrombosis D002542 5 associated lipids
Brain Ischemia D002545 89 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Choroid Neoplasms D002830 2 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Colorectal Neoplasms, Hereditary Nonpolyposis D003123 2 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Coronary Disease D003327 70 associated lipids
Congenital Hypothyroidism D003409 1 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diarrhea D003967 32 associated lipids
Dientamoebiasis D004030 1 associated lipids
Dysentery, Amebic D004404 3 associated lipids
Echinococcosis D004443 2 associated lipids
Embolism D004617 3 associated lipids
Equine Infectious Anemia D004859 1 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Fetomaternal Transfusion D005331 1 associated lipids
Glomerulonephritis D005921 35 associated lipids
Glucagonoma D005935 2 associated lipids
Granuloma D006099 5 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Heart Arrest D006323 13 associated lipids
Heart Diseases D006331 8 associated lipids
Hirschsprung Disease D006627 3 associated lipids
Hyperplasia D006965 34 associated lipids
Hypothyroidism D007037 32 associated lipids
Creutzfeldt-Jakob Syndrome D007562 7 associated lipids
Keratosis D007642 9 associated lipids
Laryngeal Neoplasms D007822 7 associated lipids
Lip Neoplasms D008048 3 associated lipids
Listeriosis D008088 12 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Medulloblastoma D008527 22 associated lipids
Meningioma D008579 11 associated lipids
Mesonephroma D008649 1 associated lipids
Metaplasia D008679 7 associated lipids
Adenoma, Pleomorphic D008949 1 associated lipids
Mouth Diseases D009059 5 associated lipids
Mycoses D009181 18 associated lipids
Myocardial Infarction D009203 21 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Neoplasms, Multiple Primary D009378 8 associated lipids
Neurilemmoma D009442 10 associated lipids
Occupational Diseases D009784 42 associated lipids
Palatal Neoplasms D010157 2 associated lipids
Paraganglioma, Extra-Adrenal D010236 1 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Poultry Diseases D011201 21 associated lipids
Precancerous Conditions D011230 48 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Rabies D011818 4 associated lipids
Respiratory Sounds D012135 3 associated lipids
Rhabdomyoma D012207 1 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Rodent Diseases D012376 4 associated lipids
Sarcoma D012509 3 associated lipids
Osteosarcoma D012516 50 associated lipids
Schistosomiasis haematobia D012553 1 associated lipids
Sertoli Cell Tumor D012707 1 associated lipids
Sigmoid Neoplasms D012811 5 associated lipids
Sinusitis D012852 9 associated lipids
Skin Neoplasms D012878 12 associated lipids
Spinal Cord Neoplasms D013120 3 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Swine Diseases D013553 16 associated lipids
Teratoma D013724 4 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Shaw MB et al. A porcine model of bladder outlet obstruction incorporating radio-telemetered cystometry. 2007 BJU Int. pmid:17552964
Phull H et al. Angiotensin II plays a role in acute murine experimental autoimmune cystitis. 2007 BJU Int. pmid:17550411
Bach T et al. 70 vs 120 W thulium:yttrium-aluminium-garnet 2 microm continuous-wave laser for the treatment of benign prostatic hyperplasia: a systematic ex-vivo evaluation. 2010 BJU Int. pmid:19912204
Breda A et al. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study. 2010 BJU Int. pmid:19888984
Yang CC et al. Sexually responsive vascular tissue of the vulva. 2006 BJU Int. pmid:16536770
Hafez AT et al. Fibrin glue for the suture-less correction of penile chordee: a pilot study in a rabbit model. 2004 BJU Int. pmid:15291882
Costello AJ et al. Immunohistochemical study of the cavernous nerves in the periprostatic region. 2011 BJU Int. pmid:20942832
El-Assmy A et al. Use of oxidized cellulose for corporal body grafting and suture-less correction of severe penile chordee: an experimental study in rabbits. 2007 BJU Int. pmid:17233810
Di Tommaso L et al. Renal calcium phosphate and oxalate deposition in prolonged vitamin B6 deficiency: studies on a rat model of urolithiasis. 2002 BJU Int. pmid:11942967
Pareek G et al. Haemostatic partial nephrectomy using bipolar radiofrequency ablation. 2005 BJU Int. pmid:16225536
Comiter C and Phull HS Angiotensin II type 1 (AT-1) receptor inhibition partially prevents the urodynamic and detrusor changes associated with bladder outlet obstruction: a mouse model. 2012 BJU Int. pmid:21939491
Dasgupta P et al. Cimetidine in painful bladder syndrome: a histopathological study. 2001 BJU Int. pmid:11488726
Schoeller T et al. Gracilis muscle flap with a tissue-engineered lining for experimental bladder wall reconstruction. 2001 BJU Int. pmid:11446857
Tewari A et al. Identification of the retrotrigonal layer as a key anatomical landmark during robotically assisted radical prostatectomy. 2006 BJU Int. pmid:16879447
Schilling D et al. Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost-benefit analysis. 2012 BJU Int. pmid:22314026
al-Saleem T Classification of lymphoid neoplasms between the hematopathologists and the "common person". 1995 Blood pmid:7535596
Conway CM et al. The development and validation of the Virtual Tissue Matrix, a software application that facilitates the review of tissue microarrays on line. 2006 BMC Bioinformatics pmid:16707006
Kovacheva VN et al. A model of the spatial tumour heterogeneity in colorectal adenocarcinoma tissue. 2016 BMC Bioinformatics pmid:27342072
Wang CW Fast automatic quantitative cell replication with fluorescent live cell imaging. 2012 BMC Bioinformatics pmid:22292799
Mete M et al. Automatic delineation of malignancy in histopathological head and neck slides. 2007 BMC Bioinformatics pmid:18047716
Hejnol A and Martindale MQ Coordinated spatial and temporal expression of Hox genes during embryogenesis in the acoel Convolutriloba longifissura. 2009 BMC Biol. pmid:19796382
Sabbir MG et al. Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform. 2010 BMC Biol. pmid:20199662
Carmona FD et al. The molecular basis of defective lens development in the Iberian mole. 2008 BMC Biol. pmid:18939978
Pask AJ et al. Oestrogen blocks the nuclear entry of SOX9 in the developing gonad of a marsupial mammal. 2010 BMC Biol. pmid:20807406
Zaibak F et al. Unrestricted somatic stem cells from human umbilical cord blood grow in serum-free medium as spheres. 2009 BMC Biotechnol. pmid:20003538
Takano EA et al. A multiplex endpoint RT-PCR assay for quality assessment of RNA extracted from formalin-fixed paraffin-embedded tissues. 2010 BMC Biotechnol. pmid:21162754
Martin CD et al. A simple vector system to improve performance and utilisation of recombinant antibodies. 2006 BMC Biotechnol. pmid:17156422
Costa-Nogueira C et al. Synthesis and expression of CDw75 antigen in human colorectal cancer. 2009 BMC Cancer pmid:20003255
Fritzsche FR et al. ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. 2008 BMC Cancer pmid:18582378
Zhang B et al. Expression of RECK and matrix metalloproteinase-2 in ameloblastoma. 2009 BMC Cancer pmid:19995435
Kahlert C et al. Low expression of aldehyde dehydrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer. 2011 BMC Cancer pmid:21708005
Pinho SS et al. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression. 2007 BMC Cancer pmid:17617904
de Kruijf EM et al. NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study. 2012 BMC Cancer pmid:22257486
Wang Q et al. Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis. 2011 BMC Cancer pmid:21702992
Gambichler T et al. Pattern of mRNA expression of beta-defensins in basal cell carcinoma. 2006 BMC Cancer pmid:16796735
Chaube A et al. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582. 2006 BMC Cancer pmid:16686942
Morgan K et al. GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines. 2011 BMC Cancer pmid:22051164
Hamtiaux L et al. The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action. 2012 BMC Cancer pmid:22429826
Kalinina T et al. Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. 2010 BMC Cancer pmid:20553613
Kim JH et al. Canine classical seminoma: a specific malignant type with human classifications is highly correlated with tumor angiogenesis. 2010 BMC Cancer pmid:20509912
Di Nicolantonio F et al. Cancer cell adaptation to chemotherapy. 2005 BMC Cancer pmid:16026610
Egerod FL et al. High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression. 2009 BMC Cancer pmid:19878561
Kalliomäki TM et al. Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model. 2008 BMC Cancer pmid:18507854
González-Reyes S et al. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. 2010 BMC Cancer pmid:21129170
Kratz JE et al. Expression of stabilized beta-catenin in differentiated neurons of transgenic mice does not result in tumor formation. 2002 BMC Cancer pmid:12460454
Chen M et al. Overexpression of eIF-5A2 in mice causes accelerated organismal aging by increasing chromosome instability. 2011 BMC Cancer pmid:21612665
Zhang D et al. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. 2010 BMC Cancer pmid:21108842
Nykopp TK et al. Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content. 2009 BMC Cancer pmid:19435493
Muinelo-Romay L et al. Identification of α(1,6)fucosylated proteins differentially expressed in human colorectal cancer. 2011 BMC Cancer pmid:22152070
Walker LG et al. Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer. 2011 BMC Cancer pmid:21592370
Ohri CM et al. Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer. 2010 BMC Cancer pmid:20429924
Tong QS et al. BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cells. 2004 BMC Cancer pmid:15248898
Morrone FB et al. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model. 2006 BMC Cancer pmid:16995949
Chanrion M et al. A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study. 2007 BMC Cancer pmid:17338809
Nordfors K et al. The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis. 2010 BMC Cancer pmid:20398423
Wu Z et al. Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma. 2009 BMC Cancer pmid:19732464
Lüchtenborg M et al. Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study. 2005 BMC Cancer pmid:16356174
Hadad SM et al. Histological evaluation of AMPK signalling in primary breast cancer. 2009 BMC Cancer pmid:19723334
Brennan DJ et al. Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer. 2010 BMC Cancer pmid:20359358
Sun S et al. A protein-based set of reference markers for liver tissues and hepatocellular carcinoma. 2009 BMC Cancer pmid:19725976
Nordentoft I et al. Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer. 2011 BMC Cancer pmid:21489314
Woelber L et al. Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer. 2011 BMC Cancer pmid:21223596
Deschoolmeester V et al. Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. 2010 BMC Cancer pmid:20346145
Szybka M et al. cDNA sequencing improves the detection of P53 missense mutations in colorectal cancer. 2009 BMC Cancer pmid:19671129
Shi H et al. Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis. 2010 BMC Cancer pmid:20815902
Kempkensteffen C et al. Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer. 2009 BMC Cancer pmid:19664236
Spindler KL et al. EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer. 2011 BMC Cancer pmid:21439039
Nykopp TK et al. Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma. 2010 BMC Cancer pmid:20875124
Hung MS et al. Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library. 2009 BMC Cancer pmid:19419583
Naguib A et al. Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study. 2010 BMC Cancer pmid:20233436
Lööf J et al. Impact of PINCH expression on survival in colorectal cancer patients. 2011 BMC Cancer pmid:21426571
Van der Auwera I et al. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients. 2010 BMC Cancer pmid:20226036
Nyalendo C et al. Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression. 2009 BMC Cancer pmid:19961596
Tomlinson VA et al. Translation elongation factor eEF1A2 is a potential oncoprotein that is overexpressed in two-thirds of breast tumours. 2005 BMC Cancer pmid:16156888
Cheng Y et al. Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. 2007 BMC Cancer pmid:17927838
Ihnen M et al. Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients. 2012 BMC Cancer pmid:22475274
Papageorgiou KI and Kaniorou-Larai MG A case report of Merkel cell carcinoma on chronic lymphocytic leukemia: differential diagnosis of coexisting lymphadenopathy and indications for early aggressive treatment. 2005 BMC Cancer pmid:16111484
Mascolo M et al. Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. 2010 BMC Cancer pmid:20178651
Zhao C et al. Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer. 2009 BMC Cancer pmid:19586554
Bedin V et al. Fractal dimension of chromatin is an independent prognostic factor for survival in melanoma. 2010 BMC Cancer pmid:20525386
Graziano F et al. Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer. 2001 BMC Cancer pmid:11518545
Malfettone A et al. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis. 2012 BMC Cancer pmid:22439624
Jörissen H et al. Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer. 2009 BMC Cancer pmid:19552806
Schneider M et al. Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker. 2012 BMC Cancer pmid:22433494
Lo Muzio L et al. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study. 2005 BMC Cancer pmid:15967043
Genelhu MC et al. A comparative study between mixed-type tumours from human salivary and canine mammary glands. 2007 BMC Cancer pmid:18045453
van Cruijsen H et al. Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer. 2009 BMC Cancer pmid:19519895
Dierssen JW et al. High-resolution analysis of HLA class I alterations in colorectal cancer. 2006 BMC Cancer pmid:17014712
Gonzalez LO et al. Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. 2008 BMC Cancer pmid:18507821
Kumar MJ et al. A mouse model for luminal epithelial like ER positive subtype of human breast cancer. 2007 BMC Cancer pmid:17880731
Seigne C et al. Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice. 2010 BMC Cancer pmid:20663219
Xiaorong L et al. Underexpression of deleted in liver cancer 2 (DLC2) is associated with overexpression of RhoA and poor prognosis in hepatocellular carcinoma. 2008 BMC Cancer pmid:18651974
Zavagno G et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. 2005 BMC Cancer pmid:15762990
Romanucci M et al. Heat shock protein expression in canine malignant mammary tumours. 2006 BMC Cancer pmid:16803633
Bacman D et al. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. 2007 BMC Cancer pmid:17692120
Toledo MT et al. Cancer during pregnancy alters the activity of rat placenta and enhances the expression of cleaved PARP, cytochrome-c and caspase 3. 2006 BMC Cancer pmid:16800886
Mesquita B et al. No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin. 2005 BMC Cancer pmid:16095531
Wang J et al. Case report: PET/CT, a cautionary tale. 2007 BMC Cancer pmid:17683560
Wu QW et al. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. 2012 BMC Cancer pmid:22284579
Macartney-Coxson DP et al. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. 2008 BMC Cancer pmid:18590575